These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1323784)

  • 21. Comparative study of hepatitis C virus antibody between hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Lee HY; Kang DH; Park CS; Kim KY; Kang SW; Kim HS; Choi KH; Ha SK; Han DS
    Yonsei Med J; 1993 Dec; 34(4):371-80. PubMed ID: 7510444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HCV incidence in a dialysis center: preliminary reports.
    Ippolito E; Aterini S; Salvadori M; D'Elia G; Amato M
    Nephron; 1992; 61(3):375-6. PubMed ID: 1323797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
    Miyasaka M
    Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavior of antibody profile against hepatitis C virus in patients on maintenance hemodialysis.
    Vandelli L; Medici G; Savazzi AM; De Palma M; Vecchi C; Zanchetta G; Lusvarghi E
    Nephron; 1992; 61(3):260-2. PubMed ID: 1323767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HCV seroprevalence in dialysis patients, their relatives and medical staff.
    Capşa D; Cernescu S; Constantinescu SN; Cernescu C
    Rev Roum Virol; 1991; 42(3-4):171-5. PubMed ID: 1667584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of antibodies to HCV in haemodialysis patients using two second generation ELISA tests.
    Dentico P; Volpe A; Buongiorno R; Fiore G; Carbone M; Manno C; Pastore G; Schiraldi O
    Ital J Gastroenterol; 1993 Jan; 25(1):19-22. PubMed ID: 7679012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of antibodies to hepatitis C virus in patients undergoing chronic dialysis and CAPD.
    Nakashima F; Sata M; Tokeshi S; Nakano H; Nakashima M; Nakashima N; Motomura K; Motomura S; Ide M; Tanikawa K
    Kurume Med J; 1993; 40(4):249-53. PubMed ID: 7516454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies against hepatitis C virus in hemodialysis patients in the central Italian region of Umbria: evaluation of some risk factors.
    Brugnano R; Francisci D; Quintaliani G; Gaburri M; Nori G; Verdura C; Giombini L; Buoncristiani U
    Nephron; 1992; 61(3):263-5. PubMed ID: 1323768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of antibodies to hepatitis C in dialysis patients and transplant recipients with possible routes of transmission.
    Conway M; Catterall AP; Brown EA; Tibbs C; Gower PE; Curtis JR; Coleman JC; Murray-Lyon IM
    Nephrol Dial Transplant; 1992; 7(12):1226-9. PubMed ID: 1283447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis G virus exposure in dialysis staff.
    Eslamifar A; Hamkar R; Ramezani A; Ahmadi F; Gachkar L; Jalilvand S; Adibi L; Khameneh A; Atabak S; Ghadimi R; Aghakhani A
    Ther Apher Dial; 2007 Oct; 11(5):370-4. PubMed ID: 17845396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus in dialysis units: a multicenter study.
    Da Porto A; Adami A; Susanna F; Calzavara P; Poli P; Castelletto MR; Amici GP; Teodori T; Okolicsanyi L
    Nephron; 1992; 61(3):309-10. PubMed ID: 1323777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the positivity of the test for anti-HCV considerations in dialized patients.
    Avella F; Irlando A; Scancariello G; Iovino R
    Nephron; 1992; 61(3):341. PubMed ID: 1323785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C infection in dialysis patients in Israel.
    Weinstein T; Tur-Kaspa R; Chagnac A; Korzets A; Ori Y; Zevin D; Herman M; Gafter U
    Isr Med Assoc J; 2001 Mar; 3(3):174-7. PubMed ID: 11303373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in prevalence of anti-HCV antibodies associated with preventive measures among hemodialysis patients and dialysis staff.
    Fujiyama S; Kawano S; Sato S; Shimada H; Matsushita K; Ikezaki N; Nakano T; Sato T
    Hepatogastroenterology; 1995 Apr; 42(2):162-5. PubMed ID: 7545641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors and clinical expression of HCV infection in hemodialysis patients.
    Pauri P; Salvoni G; Vitolo W; Carletti P; Fanciulli E; Ricciatti AM; Della Bella S; Mioli VA
    Nephron; 1992; 61(3):313-4. PubMed ID: 1323778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased prevalence of HCV antibodies in dialyzed Ashkenazi Jews--a possible ethnic predisposition.
    Golan E; Korzets Z; Cristal-Lilov A; Ben-Tovim T; Bernheim J
    Nephrol Dial Transplant; 1996 Apr; 11(4):684-6. PubMed ID: 8671859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of hepatitis C virus in dialysis patients in Spain. Spanish Multicentre Study Group.
    Nephrol Dial Transplant; 1995; 10 Suppl 6():78-80. PubMed ID: 8524503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis G virus infection in hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Noh H; Kang SW; Choi SH; Shin SK; Seo BJ; Lee IH; Choi KH; Han DS; Kim HS; Lee HY
    Yonsei Med J; 1998 Apr; 39(2):116-21. PubMed ID: 9587251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C virus in hemodialysis patients.
    Dentico P; Volpe A; Buongiorno R; Carlone A; Carbone M; Manno M
    Nephron; 1992; 61(3):307-8. PubMed ID: 1323776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The need for second-generation antihepatitis C virus testing in uremic patients on continuous ambulatory peritoneal dialysis.
    Ng YY; Lee SD; Wu SC; Liu WT; Chia WL; Huang TP
    Perit Dial Int; 1993; 13(2):132-5. PubMed ID: 7684259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.